Magnetic resonance imaging (MRI) can be used to non-invasively assess the cerebral vasculature and its function in AD, and has been widely applied to assess vascular dysfunction in APP models (for a recent review see Klohs et al., 2014). The gene discussed is APP; the disease is Alzheimer disease.